SÜSS MicroTec (SMHN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 Apr, 2026Company profile and strategic positioning
Headquartered in Germany with a 75-year history of innovation and growth, serving as a key technology provider for the semiconductor industry, especially in frontend and advanced backend segments.
Maintains a global customer base, with the largest share of business in Asia, and acts as a strategic partner for major semiconductor IDMs and foundries.
Strong ties to research institutes and universities, supporting ongoing innovation.
Product portfolio and technology leadership
Offers solutions in photomask equipment, imaging, coating, and bonding, with scalable products supporting next-generation technology nodes.
Market leader in temporary bonding and de-bonding, with expanding capabilities in permanent and hybrid wafer bonding.
Recent product launches target both high-volume manufacturing and R&D, optimizing for customer device and manufacturing needs.
Financial performance and segment analysis (2025)
Achieved record sales of €503.2 million (+12.6% YoY), surpassing half a billion euros for the first time.
Gross profit margin at 35.7% (-3.9pp YoY); EBIT margin at 13.1% (-3.6pp YoY), reflecting a less favorable product mix and higher ramp-up costs.
Advanced Backend Solutions saw 10.7% sales growth, with Imaging and Coating systems growing over 50% YoY; Photomask Solutions achieved record sales and improved profitability.
Free cash flow turned negative due to investments in new production capacity and lower customer prepayments; CapEx increased to €23.2 million.
Latest events from SÜSS MicroTec
- Record Q1 order intake drives optimism for 2026 despite weak sales and profit.SMHN
Q1 20267 May 2026 - Record 2025 sales and new product launches support ambitious 2030 growth targets.SMHN
German Select VII Conference15 Apr 2026 - Record 2025 sales of €503.2M; 2026 outlook signals lower sales and margins amid higher R&D.SMHN
Q4 20252 Apr 2026 - Sales up 45.6%, EBIT margin at 15.6%, and guidance raised on strong order momentum.SMHN
Q2 20242 Feb 2026 - Record sales and margins in 2024 set a strong outlook for 2025 despite one-off costs.SMHN
Q4 202423 Dec 2025 - Record sales and EBIT growth offset by lower order intake and margin pressure, prompting guidance cuts.SMHN
Q2 202523 Nov 2025 - Sales targeted at €750–900 million and 43–45% margin by 2030, led by innovation and services.SMHN
CMD 202521 Nov 2025 - Q1 2025 sales up 31.8%, profit surged, but order intake fell amid rising macro risks.SMHN
Q1 202521 Nov 2025 - Margin pressure and lower net income prompt guidance cut, but Q4 order rebound expected.SMHN
Q3 202513 Nov 2025